Characterization of CXCR4-using HIV-1 during primary infection by ultra-deep pyrosequencing

13Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Objectives: R5 viruses have long been thought to account for almost all strains present in primary HIV-1 infections (PHIs), but recent studies using sensitive phenotypic assays have revealed that 3%-6.4% of subjects also harbour CXCR4-using viruses. Phenotypic assays provide only qualitative results: the presence or absence of CXCR4-using viruses. We have therefore used ultra-deep pyrosequencing (UDS) to determine the frequency of CXCR4-using viruses among HIV-1 quasispecies. Methods:We first screened 200 patients for HIV-1 tropism using a sensitive phenotypic assay during PHI and identified 11 infected with an R5X4 dual/mixed (D/M) virus population.We then used UDS of the V3 env region with the geno2pheno algorithm (false positive rate=5.75) to identify the HIV-1 quasispecies. Results: CXCR4-using viruseswere detected in all but1of the11patients byUDS,andaccountedfor0.2%-100%of the virus populations. The frequency of CXCR4-using viruses was<20% in six subjects and 100% in four subjects. Virus populations containing100%CXCR4-using variants during PHI persisted forat least1-2 years after the acute phase. The CCR5 Δ32 heterozygous genotype was similarly prevalent in patients infected with D/M (27%) and R5 (15%) viruses. Conclusions: UDS and the phenotypewere concordant for determining HIV-1 coreceptor usage. UDS analysis indicated large differences in the percentage of CXCR4-using viruses in the HIV-1 quasispecies during PHI. Further studies should examine the impact of the proportion of CXCR4-using viruses on disease prognosis. © The Author 2013. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.

Cite

CITATION STYLE

APA

Raymond, S., Saliou, A., Nicot, F., Delobel, P., Dubois, M., Carcenac, R., … Izopet, J. (2013). Characterization of CXCR4-using HIV-1 during primary infection by ultra-deep pyrosequencing. Journal of Antimicrobial Chemotherapy, 68(12), 2875–2881. https://doi.org/10.1093/jac/dkt290

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free